BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38548409)

  • 1. Identification of TCR repertoire patterns linked with anti-cancer immunotherapy.
    Vandoren R; Gielis S; Laukens K; Meysman P
    Methods Cell Biol; 2024; 183():115-142. PubMed ID: 38548409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustering and Annotation of T Cell Receptor Repertoires.
    Valkiers S; Gielis S; Van Deuren VML; Laukens K; Meysman P
    Methods Mol Biol; 2023; 2673():33-51. PubMed ID: 37258905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.
    Zhang L; Cham J; Paciorek A; Trager J; Sheikh N; Fong L
    BMC Bioinformatics; 2017 Feb; 18(1):129. PubMed ID: 28241742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.
    Frank ML; Lu K; Erdogan C; Han Y; Hu J; Wang T; Heymach JV; Zhang J; Reuben A
    Clin Cancer Res; 2023 Mar; 29(6):994-1008. PubMed ID: 36413126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications.
    Li N; Yuan J; Tian W; Meng L; Liu Y
    Cancer Commun (Lond); 2020 Oct; 40(10):473-483. PubMed ID: 32677768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.
    Kidman J; Principe N; Watson M; Lassmann T; Holt RA; Nowak AK; Lesterhuis WJ; Lake RA; Chee J
    Front Immunol; 2020; 11():587014. PubMed ID: 33163002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing.
    Peng K; Nowicki TS; Campbell K; Vahed M; Peng D; Meng Y; Nagareddy A; Huang YN; Karlsberg A; Miller Z; Brito J; Nadel B; Pak VM; Abedalthagafi MS; Burkhardt AM; Alachkar H; Ribas A; Mangul S
    Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37291798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapy.
    Joshi K; Milighetti M; Chain BM
    Curr Opin Immunol; 2022 Feb; 74():1-8. PubMed ID: 34454284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering based approach for population level identification of condition-associated T-cell receptor β-chain CDR3 sequences.
    Yohannes DA; Kaukinen K; Kurppa K; Saavalainen P; Greco D
    BMC Bioinformatics; 2021 Mar; 22(1):159. PubMed ID: 33765908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR repertoire evolution during maintenance of CMV-specific T-cell populations.
    Schober K; Buchholz VR; Busch DH
    Immunol Rev; 2018 May; 283(1):113-128. PubMed ID: 29664573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1.
    Poran A; Scherer J; Bushway ME; Besada R; Balogh KN; Wanamaker A; Williams RG; Prabhakara J; Ott PA; Hu-Lieskovan S; Khondker ZS; Gaynor RB; Rooney MS; Srinivasan L
    Cell Rep Med; 2020 Nov; 1(8):100141. PubMed ID: 33294862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-GITR Antibody Treatment Increases TCR Repertoire Diversity of Regulatory but not Effector T Cells Engaged in the Immune Response Against B16 Melanoma.
    Scirka B; Szurek E; Pietrzak M; Rempala G; Kisielow P; Ignatowicz L; Miazek A
    Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):553-564. PubMed ID: 28638937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals.
    Huisman W; Hageman L; Leboux DAT; Khmelevskaya A; Efimov GA; Roex MCJ; Amsen D; Falkenburg JHF; Jedema I
    Front Immunol; 2022; 13():851868. PubMed ID: 35401538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing.
    Bai H; Ma J; Mao W; Zhang X; Nie Y; Hao J; Wang X; Qin H; Zeng Q; Hu F; Qi X; Chen X; Li D; Zhang B; Shi B; Zhang C
    Blood Cells Mol Dis; 2022 Nov; 97():102678. PubMed ID: 35716403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
    Genolet R; Bobisse S; Chiffelle J; Arnaud M; Petremand R; Queiroz L; Michel A; Reichenbach P; Cesbron J; Auger A; Baumgaertner P; Guillaume P; Schmidt J; Irving M; Kandalaft LE; Speiser DE; Coukos G; Harari A
    Cell Rep Methods; 2023 Apr; 3(4):100459. PubMed ID: 37159666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Enriched T Cell Epitope Specificity in Full T Cell Receptor Sequence Repertoires.
    Gielis S; Moris P; Bittremieux W; De Neuter N; Ogunjimi B; Laukens K; Meysman P
    Front Immunol; 2019; 10():2820. PubMed ID: 31849987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeepLION2: deep multi-instance contrastive learning framework enhancing the prediction of cancer-associated T cell receptors by attention strategy on motifs.
    Qian X; Yang G; Li F; Zhang X; Zhu X; Lai X; Xiao X; Wang T; Wang J
    Front Immunol; 2024; 15():1345586. PubMed ID: 38515756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies.
    Ye B; Smerin D; Gao Q; Kang C; Xiong X
    Cancer Lett; 2018 Mar; 416():42-56. PubMed ID: 29247824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
    Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.